Track the 셀트리온 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 셀트리온 has logged 29 reports. Market capitalisation: €41,622.9bn. The latest transaction was disclosed on 10 July 2026 (Purchase). Among the most active insiders: 장소용. The full history is accessible without an account.
28
Insider Decl.
n/a
Thresholds
€714,238
24 ops.
Buy Volume
€366,075
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 셀트리온 Buy (bullish), based on 24 analysts. Average price target: ₩265,216.
36Σ signal
Buys €714,238€366,075 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 15,501 of 29,062 companies
50.2
score / 100
Value
34
Quality
67
FCF yld0.7%
Earn yld2.4%
EV/EBITDA30.9x
ROE9.1%
Gross mgn59%
Net mgn25%
Debt/EBITDA2.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
2,173 shares@ ₩139,147.000.0000% mcap100.0% of flowShareKRXDART:20260430001734
25 of 29 declarations
Acerca de 셀트리온
Celltrion es una empresa surcoreana centrada en el desarrollo y la fabricación de medicamentos biosimilares y terapias biológicas. Cotiza en la Bolsa de Corea, XKRX.